We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
1926
DELISTED
Berry Corp
BRY
| $74.4K | ﹤0.01% |
14,474
+4,375
| +43% | +$26.7K |
|
|
CNSL
1927
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $74.3K | ﹤0.01% |
16,008
+4,421
| +38% | +$20.1K |
|
|
FFWM
1928
DELISTED
First Foundation Inc
FFWM
| $74.1K | ﹤0.01% |
+11,872
| New | +$75.9K |
|
1929
TETRA Technologies
TTI
$1.23B
| $73.5K | ﹤0.01% |
23,723
+6,932
| +41% | +$22.4K |
|
1930
Getty Images
GETY
$184M
| $72.2K | ﹤0.01% |
+18,958
| New | +$66.8K |
|
1931
Kearny Financial
KRNY
$592M
| $71.1K | ﹤0.01% |
+10,349
| New | +$68.3K |
|
1932
Unisys
UIS
$227M
| $70.7K | ﹤0.01% |
12,442
-5,370
| -30% | -$26.6K |
|
|
ACRE
1933
Ares Commercial Real Estate
ACRE
$252M
| $70.7K | ﹤0.01% |
+10,095
| New | +$72.5K |
|
|
BLDP
1934
Ballard Power Systems
BLDP
$874M
| $70.1K | ﹤0.01% |
38,923
+120
| +0.3% | +$240 |
|
1935
Editas Medicine
EDIT
$399M
| $70K | ﹤0.01% |
20,534
+4,439
| +28% | +$19.3K |
|
1936
Aquestive Therapeutics
AQST
$462M
| $69.9K | ﹤0.01% |
+14,032
| New | +$54.6K |
|
|
IAUX
1937
i-80 Gold Corp
IAUX
$1.17B
| $69.4K | ﹤0.01% |
59,829
+33,394
| +126% | +$35K |
|
1938
Advantage Solutions
ADV
$484M
| $69.4K | ﹤0.01% |
809
+343
| +74% | +$31.6K |
|
|
MPT
1939
Medical Properties Trust
MPT
$2.89B
| $69K | ﹤0.01% |
11,795
-190
| -2% | -$937 |
|
1940
Prime Medicine
PRME
$533M
| $68.9K | ﹤0.01% |
17,811
+5,104
| +40% | +$23.6K |
|
1941
Lexicon Pharmaceuticals
LXRX
$1.02B
| $67.6K | ﹤0.01% |
43,056
+8,331
| +24% | +$14.8K |
|
1942
Vanda Pharmaceuticals
VNDA
$312M
| $66.7K | ﹤0.01% |
14,216
+3,058
| +27% | +$16.4K |
|
1943
Fate Therapeutics
FATE
$281M
| $66.2K | ﹤0.01% |
18,917
+7,566
| +67% | +$29.4K |
|
1944
Nokia
NOK
$50.8B
| $66.1K | ﹤0.01% |
15,129
+781
| +5% | +$3.16K |
|
1945
Hyliion Holdings
HYLN
$663M
| $66K | ﹤0.01% |
26,630
+6,628
| +33% | +$13.3K |
|
1946
Atea Pharmaceuticals
AVIR
$379M
| $65.6K | ﹤0.01% |
19,570
+4,104
| +27% | +$14.9K |
|
1947
Montauk Renewables
MNTK
$266M
| $65K | ﹤0.01% |
+12,471
| New | +$62.3K |
|
1948
GrafTech
EAF
$194M
| $64.6K | ﹤0.01% |
4,892
+2,295
| +88% | +$19.1K |
|
1949
DocGo
DCGO
$58.9M
| $63.8K | ﹤0.01% |
19,216
+8,797
| +84% | +$29.9K |
|
1950
C4 Therapeutics
CCCC
$376M
| $63.1K | ﹤0.01% |
+11,079
| New | +$66.7K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.